Getting into a healthy 'CV success zone': Effective strategies to prevent CVD

European Heart Journal, Supplement

Volumn 9, Issue B, 2007, Pages

  Rieder, Anita ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 63849096971     PISSN: 1520765X     EISSN: None     Source Type: Journal    
DOI: 10.1093/eurheartj/sum001     Document Type: Article

References (32)

1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He Jiang. Global burden of hypertension: analysis of worldwide data. Lancet 2005;365:217-223.
2. WHO, World Health Organisation. European Health Report, 2005.
3. Kaplan NM, Opie LH. Controversies in hypertension. Lancet 2006;367:168-176; (Ezzati et al. PloS Med 2005;2:e133).
4. Williams B. Evolution of hypertensive disease: a revolution in guidelines. Lancet 2006;368:6-8.
5. Oliveria SA, Chen RS, McCarthy BD, Davis CC, Hill MN. Hypertension knowledge, awareness, and attitudes in a hypertensive population. Gen Intern Med 2005;20:219-225.
6. Schmeiser-Rieder A, Kunze U. Blood pressure awareness in Austria. A 20-year evaluation, 1978-1998. Eur Heart J 2000;21:414-420.
7. Rieder A, Dorner T, Hübel U, Antes G, Strunz B, Schmidl H. 'Ein Herz für Wien' - eine Stadt widmet sich der Herzgesundheit ihrer Bewohner. Weißbuch Prävention Herzgesund?Jahresreport der Kaufmännische Krankenkasse, 2004.
8. Dorner T, Fodor JG, Allichhammer D, Kiefer I, Lawrence K, Slovinec D'angelo M, Huebel U, Strunz B, Ohnoutka A, Antes G, Schmidl H, Kunze M, Rieder A. 'A heart for Vienna' - the prevention program for the big city. Blue-collar workers as a special target group. Wien Med Wochenschr 2006;156:552-557.
9. Fodor J, Lietava J, Rieder A, Sonkodi S, Emmons T, Turton P. Work-site hypertension prevalence and control in three central European countries. J Hum Hypertens 2004;18:581-585.
10. Boersma E, Keil U, De Bacquer D, De Backer G, Pyorala K, Poldersmans D, Leprotti C, Pilotto L, de Swart E, Deckers JW, Heidrich J, Sans S, Kotseva K, Wood D, Ambrosio GB, EUROASPIRE I II Study Groups. Blood pressure is insufficiently controlled in European patients with established coronary heart disease. J Hypertens 2003;21:1831-1840.
11. Wolf-Maier K, Cooper RS, Kramer H, Banegas JR, Giampaoli S, Joffres MR, Poulter N, Primatesta P, Stegmayr B, Thamm M. Hypertension treatment and control in five European countries, Canada and the United States. Hypertension 2004;43:10-17.
12. Fodor GJ, Kotrec M, Bacskai K, Dorner T, Lietava J, Sonkodi S, Rieder A, Turton P. Is interview a reliable method to verify the compliance with antihypertensive therapy? An international central-European study. J Hypertens 2005;23:1261-1266.
13. Hyman DJ, Pavlik VN, Vallbona C. Physician role in lack of awareness and control of hypertension. J Clin Hypertens 2000;2:324-330.
14. Banegas JR, Segura J, Ruilope LM, Luque M, Garcia-Robles R, Campo C, Rodriguez-Artalejo F, Tamargo J, CLUE study group investigators. Blood pressure control and physician management of hypertension in hospital hypertension units in Spain. Hypertension 2004;43:1338-1344.
15. Okonofua EC, Simpson KN, Jesri A, Rehman SU, Durkalski VL, Egan BM. Therapeutic inertia is an impediment to achieving the Healthy People 2010 blood pressure control goals. Hypertension 2006;47:345-351.
16. Flack JM, Casciano R, Casciano J, Doyle J, Arikian S, Tang S, Arocho R. Cardiovascular disease costs associated with uncontrolled hypertension. Manag Care Interface 2002;15:28-36.
17. Long G, Cutler DM, Berndt ER. Antihypertensive drugs: a perspective on the value of improved blood pressure control in the USA. Eur Heart J Suppl 2007;9:B19-B22.
18. Lloyd A, Schmieder C, Marchant N. Financial and health costs of uncontrolled blood pressure in the United Kingdom. Pharmacoeconomics 2003;21(Suppl. 1):33-41.
19. Hansson L, Lloyd A, Anderson P, Kopp Z. Excess morbidity and cost of failure to achieve targets for blood pressure control in Europe. Blood Press 2002;11:35-45.
20. Vorsorgeuntersuchung NEU. http://www.sozialversicherung.at/esvapps/page/ page.jsp?p-pageid=110&p-id=3&p-menuid=59337.
21. Wood D. The concept of doctor targets based on quality guidelines: focus on blood pressure. Eur Heart J Suppl 2007;9:B29-B36.
22. Szirmai LA, Arnold C, Farsang C. Improving control of hypertension by an integrated approach - results of the 'Manage it well!' programme. J Hypertens 2005;23:203-211.
23. Roumie CL, Elasy TA, Greevy R, Griffin MR, Liu X, Stone WJ, Wallston KA, Dittus RS, Alvarez V, Cobb J, Speroff T. Improving blood pressure control through provider education, provider alerts, and patient education - a cluster randomized trial. Ann Intern Med 2006;145:165-175.
24. Califf RM. The cycle of quality as a model for improving health outcomes in the treatment of hypertension. Eur Heart J Suppl 2007;9:B8-B12.
25. Liau CS, Fujita T, Shimamoto K, Wu Z, Zhu J, Chung NS, Park JB, Lee YT, Chen MF. What are the education programmes needed for doctors and patients in the promotion of blood pressure control? Int J Clin Pract Suppl 2006;150:23-25.
26. Campbell NR, Petrellea R, Kaczorowski J. Public education on hypertension: a new initiative to improve the prevention, treatment and control of hypertension in Canada. Can J Cardiol 2006;22:599-603.
27. Glasspool J. Adherence: a major unmet meed. CV success zone programme. Eur Heart J Suppl 2007;9:B37-B41.
28. Schaefer C. Quality of life and self monitoring: CVD prevention in practice. The role of patient organizations in CVD prevention. Eur Heart J Suppl 2007;9:B42-B44.
29. Redwood H. Hypertension, society and public policy. Eur Heart J Suppl 2007;9:B13-B18.
30. MacMahon S, Neal B, Rodgers A. Hypertension - time to move on. Lancet 2005;365:1108-1109.
31. Chiuve SE, McCullough ML, Sacks FM, Rimm EB. Healthy lifestyle factors in the primary prevention of coronary heart disease among men: benefits among users and nonusers of lipid-lowering and antihypertensive medications. Circulation 2006;114:160-167.
32. He FJ, MacGregor G. Blood pressure is the most important cause of death and disability in the world. Eur Heart J Suppl 2007;9:B23-B28.